
Our priority is to provide solutions to the needs of patients in the form of effective and safe therapies. We are leaders on the market of new generation drugs in many therapeutic groups such as cardiology, psychiatry, pulmonology, gynecology as well as treatment of urinary tract infections. We are investing in research of innovative therapies to treat major civilizational diseases - diabetes and cancer. We are working to develop new formulations of generic drugs which guarantee the highest quality and safety at a reasonable price for patients.